PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-0.91%
Negative revenue growth while ADI stands at 0.73%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
6.12%
Positive gross profit growth while ADI is negative. John Neff would see a clear operational edge over the competitor.
-72.73%
Negative EBIT growth while ADI is at 10.80%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-72.73%
Negative operating income growth while ADI is at 10.80%. Joel Greenblatt would press for urgent turnaround measures.
372.73%
Net income growth above 1.5x ADI's 9.26%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
200.00%
EPS growth under 50% of ADI's 1300.00%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
200.00%
Diluted EPS growth under 50% of ADI's 1200.00%. Michael Burry would worry about an eroding competitive position or excessive dilution.
0.25%
Slight or no buybacks while ADI is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.48%
Diluted share reduction more than 1.5x ADI's 5.29%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
-0.25%
Dividend reduction while ADI stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
786.67%
OCF growth above 1.5x ADI's 12.81%. David Dodd would confirm a clear edge in underlying cash generation.
125.30%
FCF growth similar to ADI's 138.46%. Walter Schloss would attribute it to parallel capital spending and operational models.
11.86%
10Y revenue/share CAGR under 50% of ADI's 161.99%. Michael Burry would suspect a lasting competitive disadvantage.
-14.43%
Negative 5Y CAGR while ADI stands at 66.67%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-35.92%
Negative 3Y CAGR while ADI stands at 118.96%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
11.67%
Below 50% of ADI's 153.82%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
-24.52%
Negative 3Y OCF/share CAGR while ADI stands at 219.95%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-54.44%
Negative 10Y net income/share CAGR while ADI is at 0.00%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-61.41%
Negative 5Y net income/share CAGR while ADI is 286.76%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-82.09%
Negative 3Y CAGR while ADI is 154.96%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
131.78%
5Y equity/share CAGR is in line with ADI's 143.89%. Walter Schloss would see parallel mid-term profitability and retention policies.
60.37%
Below 50% of ADI's 210.74%. Michael Burry suspects a serious short-term disadvantage in building book value.
87.55%
Dividend/share CAGR of 87.55% while ADI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
14.29%
Dividend/share CAGR of 14.29% while ADI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
37.39%
3Y dividend/share CAGR of 37.39% while ADI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-5.10%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-9.02%
Inventory is declining while ADI stands at 10.56%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-1.16%
Negative asset growth while ADI invests at 4.36%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-0.55%
We have a declining book value while ADI shows 7.49%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-0.23%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-6.71%
Our R&D shrinks while ADI invests at 2.18%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
25.55%
SG&A growth well above ADI's 2.52%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.